PDF - 5.80 MB - 135 pages - CDC › publication › fulltext › Echovirus... › publication › fulltext › Echovirus...by R Methicillin-resistant · Related articlesAug 6, 2004 — Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against ..
pages 519–648
EDITOR-IN-CHIEF D. Peter Drotman
EDITORIAL STAFF Founding Editor Joseph E. McDade, Rome, Georgia, USA Managing Senior Editor Polyxeni Potter, Atlanta, Georgia, USA Associate Editors Charles Ben Beard, Ft. Collins, Colorado, USA David Bell, Atlanta, Georgia, USA Patrice Courvalin, Paris, France Stephanie James, Bethesda, Maryland, USA Brian W.J. Mahy, Atlanta, Georgia, USA Takeshi Kurata, Tokyo, Japan Martin I. Meltzer, Atlanta, Georgia, USA David Morens, Bethesda, Maryland, USA J. Glenn Morris, Baltimore, Maryland, USA Tanja Popovic, Atlanta, Georgia, USA Patricia M. Quinlisk, Des Moines, Iowa, USA Gabriel Rabinovich, Buenos Aires, Argentina Didier Raoult, Marseilles, France Pierre Rollin, Atlanta, Georgia, USA David Walker, Galveston, Texas, USA Henrik C. Wegener, Copenhagen, Denmark Copy Editors Angie Frey, Ronnie Henry, Anne Mather, Carol Snarey, Cathy Young Production Reginald Tucker, Ann Jordan, Maureen Marshall Editorial Assistant Carolyn Collins
www.cdc.gov/eid Emerging Infectious Diseases Emerging Infectious Diseases is published monthly by the National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop D61, Atlanta, GA 30333, USA. Telephone 404-371-5329, fax 404-371-5449, email
[email protected]. The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the Centers for Disease Control and Prevention or the institutions with which the authors are affiliated. All material published in Emerging Infectious Diseases is in the public domain and may be used and reprinted without special permission; proper citation, however, is required. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services. ∞ Emerging Infectious Diseases is printed on acid-free paper that meets the requirements of ANSI/NISO 239.48-1992 (Permanence of Paper)
EDITORIAL BOARD Dennis Alexander, Addlestone Surrey, United Kingdom Ban Allos, Nashville, Tennessee, USA Michael Apicella, Iowa City, Iowa, USA Barry J. Beaty, Ft. Collins, Colorado, USA Martin J. Blaser, New York, New York, USA David Brandling-Bennet, Washington, D.C., USA Donald S. Burke, Baltimore, Maryland, USA Jay C. Butler, Anchorage, Alaska Charles H. Calisher, Ft. Collins, Colorado, USA Arturo Casadevall, New York, New York, USA Kenneth C. Castro, Atlanta, Georgia, USA Thomas Cleary, Houston, Texas, USA Anne DeGroot, Providence, Rhode Island, USA Vincent Deubel, Shanghai, China Ed Eitzen, Washington, D.C., USA Duane J. Gubler, Honolulu, Hawaii, USA Scott Halstead, Arlington, Virginia, USA David L. Heymann, Geneva, Switzerland Sakae Inouye, Tokyo, Japan Charles King, Cleveland, Ohio, USA Keith Klugman, Atlanta, Georgia, USA S.K. Lam, Kuala Lumpur, Malaysia Bruce R. Levin, Atlanta, Georgia, USA Myron Levine, Baltimore, Maryland, USA Stuart Levy, Boston, Massachusetts, USA John S. MacKenzie, Brisbane, Australia Tom Marrie, Edmonton, Alberta, Canada John E. McGowan, Jr., Atlanta, Georgia, USA Stephen S. Morse, New York, New York, USA Philip P. Mortimer, London, United Kingdom Fred A. Murphy, Davis, California, USA Barbara E. Murray, Houston, Texas, USA P. Keith Murray, Ames, Iowa, USA Stephen Ostroff, Atlanta, Georgia, USA Rosanna W. Peeling, Geneva, Switzerland David H. Persing, Seattle, Washington, USA Gianfranco Pezzino, Topeka, Kansas, USA Richard Platt, Boston, Massachusetts, USA Mario Raviglione, Geneva, Switzerland Leslie Real, Atlanta, Georgia, USA David Relman, Palo Alto, California, USA Nancy Rosenstein, Atlanta, Georgia, USA Connie Schmaljohn, Frederick, Maryland, USA Tom Schwan, Hamilton, Montana, USA Ira Schwartz, Valhalla, New York, USA Tom Shinnick, Atlanta, Georgia, USA Patricia Simone, Atlanta, Georgia, USA Bonnie Smoak, Bethesda, Maryland, USA Rosemary Soave, New York, New York, USA P. Frederick Sparling, Chapel Hill, North Carolina, USA Jan Svoboda, Prague, Czech Republic Bala Swaminathan, Atlanta, Georgia, USA Robert Swanepoel, Johannesburg, South Africa Phillip Tarr, Seattle, Washington, USA Timothy Tucker, Cape Town, South Africa Elaine Tuomanen, Memphis, Tennessee, USA Mary E. Wilson, Cambridge, Massachusetts, USA John Ward, Atlanta, Georgia, USA
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 4, April 2005
A Peer-Reviewed Journal Tracking and Analyzing Disease Trends
Vol. 11, No. 4, April 2005
Infecting Prairie Dogs with Monkeypox Virus . . . . . . . . . . .539 S.-Y. Xiao et al. Infected prairie dogs can transmit monkeypox virus by respiratory and mucocutaneous contact with susceptible animals and humans.
Antimicrobial-resistant Escherichia coli, Spain . . . . . . . . . .546 J. Oteo et al. Antimicrobial resistance, particularly to fluoroquinolones and third-generation cephalosporins, is increasing in E. coli in Spain.
Staphylococcus aureus Bacteremia, Australia . . . . . . . . . . .554
On the Cover
P. Collignon et al. S. aureus bacteremia in Australia is increasingly caused by MRSA, which is likely to affect empiric prescribing o
